Global CMO and CDMO biotechnology Market Research Report 2022 - Market Study Report

Global CMO and CDMO biotechnology Market Research Report 2022

Report Format: PDF | Report ID: 5435518 | Published Date: August 05, 2022

Choose License
Market Analysis and Insights: Global CMO and CDMO biotechnology Market
The global CMO and CDMO biotechnology market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Service accounting for % of the CMO and CDMO biotechnology global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Large Enterprise segment is altered to an % CAGR throughout this forecast period.
China CMO and CDMO biotechnology market size is valued at US$  million in 2021, while the North America and Europe CMO and CDMO biotechnology are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe CMO and CDMO biotechnology landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CMO and CDMO biotechnology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CMO and CDMO biotechnology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CMO and CDMO biotechnology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CMO and CDMO biotechnology market.
Global CMO and CDMO biotechnology Scope and Market Size
CMO and CDMO biotechnology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CMO and CDMO biotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Service
    Product
    Platform/ Expression System
Segment by Application
    Large Enterprise
    SME
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Patheon
    Catalent
    Samsung Biologics
    Lonza.
    Boehringer Ingelheim
    Samsung BioLogics
    AGC Biologics
    WuXi Biologics
    AbbVie
    Avid Bioservices
    Fujifilm Diosynth Biotechnologies
    KBI Biopharma (JSR Corporation)
    Cytovance Biologics
    Xpress Biologic
    Rentschler Biopharma
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CMO and CDMO biotechnology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Service
        1.2.3 Product
        1.2.4 Platform/ Expression System
    1.3 Market by Application
        1.3.1 Global CMO and CDMO biotechnology Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Large Enterprise
        1.3.3 SME
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CMO and CDMO biotechnology Market Perspective (2017-2028)
    2.2 CMO and CDMO biotechnology Growth Trends by Region
        2.2.1 CMO and CDMO biotechnology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CMO and CDMO biotechnology Historic Market Size by Region (2017-2022)
        2.2.3 CMO and CDMO biotechnology Forecasted Market Size by Region (2023-2028)
    2.3 CMO and CDMO biotechnology Market Dynamics
        2.3.1 CMO and CDMO biotechnology Industry Trends
        2.3.2 CMO and CDMO biotechnology Market Drivers
        2.3.3 CMO and CDMO biotechnology Market Challenges
        2.3.4 CMO and CDMO biotechnology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CMO and CDMO biotechnology Players by Revenue
        3.1.1 Global Top CMO and CDMO biotechnology Players by Revenue (2017-2022)
        3.1.2 Global CMO and CDMO biotechnology Revenue Market Share by Players (2017-2022)
    3.2 Global CMO and CDMO biotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CMO and CDMO biotechnology Revenue
    3.4 Global CMO and CDMO biotechnology Market Concentration Ratio
        3.4.1 Global CMO and CDMO biotechnology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CMO and CDMO biotechnology Revenue in 2021
    3.5 CMO and CDMO biotechnology Key Players Head office and Area Served
    3.6 Key Players CMO and CDMO biotechnology Product Solution and Service
    3.7 Date of Enter into CMO and CDMO biotechnology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CMO and CDMO biotechnology Breakdown Data by Type
    4.1 Global CMO and CDMO biotechnology Historic Market Size by Type (2017-2022)
    4.2 Global CMO and CDMO biotechnology Forecasted Market Size by Type (2023-2028)
5 CMO and CDMO biotechnology Breakdown Data by Application
    5.1 Global CMO and CDMO biotechnology Historic Market Size by Application (2017-2022)
    5.2 Global CMO and CDMO biotechnology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CMO and CDMO biotechnology Market Size (2017-2028)
    6.2 North America CMO and CDMO biotechnology Market Size by Country (2017-2022)
    6.3 North America CMO and CDMO biotechnology Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe CMO and CDMO biotechnology Market Size (2017-2028)
    7.2 Europe CMO and CDMO biotechnology Market Size by Country (2017-2022)
    7.3 Europe CMO and CDMO biotechnology Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CMO and CDMO biotechnology Market Size (2017-2028)
    8.2 Asia-Pacific CMO and CDMO biotechnology Market Size by Country (2017-2022)
    8.3 Asia-Pacific CMO and CDMO biotechnology Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America CMO and CDMO biotechnology Market Size (2017-2028)
    9.2 Latin America CMO and CDMO biotechnology Market Size by Country (2017-2022)
    9.3 Latin America CMO and CDMO biotechnology Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CMO and CDMO biotechnology Market Size (2017-2028)
    10.2 Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2017-2022)
    10.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Patheon
        11.1.1 Patheon Company Detail
        11.1.2 Patheon Business Overview
        11.1.3 Patheon CMO and CDMO biotechnology Introduction
        11.1.4 Patheon Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.1.5 Patheon Recent Development
    11.2 Catalent
        11.2.1 Catalent Company Detail
        11.2.2 Catalent Business Overview
        11.2.3 Catalent CMO and CDMO biotechnology Introduction
        11.2.4 Catalent Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.2.5 Catalent Recent Development
    11.3 Samsung Biologics
        11.3.1 Samsung Biologics Company Detail
        11.3.2 Samsung Biologics Business Overview
        11.3.3 Samsung Biologics CMO and CDMO biotechnology Introduction
        11.3.4 Samsung Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.3.5 Samsung Biologics Recent Development
    11.4 Lonza.
        11.4.1 Lonza. Company Detail
        11.4.2 Lonza. Business Overview
        11.4.3 Lonza. CMO and CDMO biotechnology Introduction
        11.4.4 Lonza. Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.4.5 Lonza. Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Introduction
        11.5.4 Boehringer Ingelheim Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 Samsung BioLogics
        11.6.1 Samsung BioLogics Company Detail
        11.6.2 Samsung BioLogics Business Overview
        11.6.3 Samsung BioLogics CMO and CDMO biotechnology Introduction
        11.6.4 Samsung BioLogics Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.6.5 Samsung BioLogics Recent Development
    11.7 AGC Biologics
        11.7.1 AGC Biologics Company Detail
        11.7.2 AGC Biologics Business Overview
        11.7.3 AGC Biologics CMO and CDMO biotechnology Introduction
        11.7.4 AGC Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.7.5 AGC Biologics Recent Development
    11.8 WuXi Biologics
        11.8.1 WuXi Biologics Company Detail
        11.8.2 WuXi Biologics Business Overview
        11.8.3 WuXi Biologics CMO and CDMO biotechnology Introduction
        11.8.4 WuXi Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.8.5 WuXi Biologics Recent Development
    11.9 AbbVie
        11.9.1 AbbVie Company Detail
        11.9.2 AbbVie Business Overview
        11.9.3 AbbVie CMO and CDMO biotechnology Introduction
        11.9.4 AbbVie Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.9.5 AbbVie Recent Development
    11.10 Avid Bioservices
        11.10.1 Avid Bioservices Company Detail
        11.10.2 Avid Bioservices Business Overview
        11.10.3 Avid Bioservices CMO and CDMO biotechnology Introduction
        11.10.4 Avid Bioservices Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.10.5 Avid Bioservices Recent Development
    11.11 Fujifilm Diosynth Biotechnologies
        11.11.1 Fujifilm Diosynth Biotechnologies Company Detail
        11.11.2 Fujifilm Diosynth Biotechnologies Business Overview
        11.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Introduction
        11.11.4 Fujifilm Diosynth Biotechnologies Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.11.5 Fujifilm Diosynth Biotechnologies Recent Development
    11.12 KBI Biopharma (JSR Corporation)
        11.12.1 KBI Biopharma (JSR Corporation) Company Detail
        11.12.2 KBI Biopharma (JSR Corporation) Business Overview
        11.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Introduction
        11.12.4 KBI Biopharma (JSR Corporation) Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.12.5 KBI Biopharma (JSR Corporation) Recent Development
    11.13 Cytovance Biologics
        11.13.1 Cytovance Biologics Company Detail
        11.13.2 Cytovance Biologics Business Overview
        11.13.3 Cytovance Biologics CMO and CDMO biotechnology Introduction
        11.13.4 Cytovance Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.13.5 Cytovance Biologics Recent Development
    11.14 Xpress Biologic
        11.14.1 Xpress Biologic Company Detail
        11.14.2 Xpress Biologic Business Overview
        11.14.3 Xpress Biologic CMO and CDMO biotechnology Introduction
        11.14.4 Xpress Biologic Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.14.5 Xpress Biologic Recent Development
    11.15 Rentschler Biopharma
        11.15.1 Rentschler Biopharma Company Detail
        11.15.2 Rentschler Biopharma Business Overview
        11.15.3 Rentschler Biopharma CMO and CDMO biotechnology Introduction
        11.15.4 Rentschler Biopharma Revenue in CMO and CDMO biotechnology Business (2017-2022)
        11.15.5 Rentschler Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global CMO and CDMO biotechnology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Service Table 3. Key Players of Product Table 4. Key Players of Platform/ Expression System Table 5. Global CMO and CDMO biotechnology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global CMO and CDMO biotechnology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global CMO and CDMO biotechnology Market Size by Region (2017-2022) & (US$ Million) Table 8. Global CMO and CDMO biotechnology Market Share by Region (2017-2022) Table 9. Global CMO and CDMO biotechnology Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global CMO and CDMO biotechnology Market Share by Region (2023-2028) Table 11. CMO and CDMO biotechnology Market Trends Table 12. CMO and CDMO biotechnology Market Drivers Table 13. CMO and CDMO biotechnology Market Challenges Table 14. CMO and CDMO biotechnology Market Restraints Table 15. Global CMO and CDMO biotechnology Revenue by Players (2017-2022) & (US$ Million) Table 16. Global CMO and CDMO biotechnology Market Share by Players (2017-2022) Table 17. Global Top CMO and CDMO biotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO biotechnology as of 2021) Table 18. Ranking of Global Top CMO and CDMO biotechnology Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by CMO and CDMO biotechnology Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players CMO and CDMO biotechnology Product Solution and Service Table 22. Date of Enter into CMO and CDMO biotechnology Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global CMO and CDMO biotechnology Market Size by Type (2017-2022) & (US$ Million) Table 25. Global CMO and CDMO biotechnology Revenue Market Share by Type (2017-2022) Table 26. Global CMO and CDMO biotechnology Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global CMO and CDMO biotechnology Revenue Market Share by Type (2023-2028) Table 28. Global CMO and CDMO biotechnology Market Size by Application (2017-2022) & (US$ Million) Table 29. Global CMO and CDMO biotechnology Revenue Market Share by Application (2017-2022) Table 30. Global CMO and CDMO biotechnology Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global CMO and CDMO biotechnology Revenue Market Share by Application (2023-2028) Table 32. North America CMO and CDMO biotechnology Market Size by Country (2017-2022) & (US$ Million) Table 33. North America CMO and CDMO biotechnology Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe CMO and CDMO biotechnology Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe CMO and CDMO biotechnology Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific CMO and CDMO biotechnology Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America CMO and CDMO biotechnology Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America CMO and CDMO biotechnology Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa CMO and CDMO biotechnology Market Size by Country (2023-2028) & (US$ Million) Table 42. Patheon Company Detail Table 43. Patheon Business Overview Table 44. Patheon CMO and CDMO biotechnology Product Table 45. Patheon Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 46. Patheon Recent Development Table 47. Catalent Company Detail Table 48. Catalent Business Overview Table 49. Catalent CMO and CDMO biotechnology Product Table 50. Catalent Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 51. Catalent Recent Development Table 52. Samsung Biologics Company Detail Table 53. Samsung Biologics Business Overview Table 54. Samsung Biologics CMO and CDMO biotechnology Product Table 55. Samsung Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 56. Samsung Biologics Recent Development Table 57. Lonza. Company Detail Table 58. Lonza. Business Overview Table 59. Lonza. CMO and CDMO biotechnology Product Table 60. Lonza. Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 61. Lonza. Recent Development Table 62. Boehringer Ingelheim Company Detail Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim CMO and CDMO biotechnology Product Table 65. Boehringer Ingelheim Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 66. Boehringer Ingelheim Recent Development Table 67. Samsung BioLogics Company Detail Table 68. Samsung BioLogics Business Overview Table 69. Samsung BioLogics CMO and CDMO biotechnology Product Table 70. Samsung BioLogics Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 71. Samsung BioLogics Recent Development Table 72. AGC Biologics Company Detail Table 73. AGC Biologics Business Overview Table 74. AGC Biologics CMO and CDMO biotechnology Product Table 75. AGC Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 76. AGC Biologics Recent Development Table 77. WuXi Biologics Company Detail Table 78. WuXi Biologics Business Overview Table 79. WuXi Biologics CMO and CDMO biotechnology Product Table 80. WuXi Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 81. WuXi Biologics Recent Development Table 82. AbbVie Company Detail Table 83. AbbVie Business Overview Table 84. AbbVie CMO and CDMO biotechnology Product Table 85. AbbVie Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 86. AbbVie Recent Development Table 87. Avid Bioservices Company Detail Table 88. Avid Bioservices Business Overview Table 89. Avid Bioservices CMO and CDMO biotechnology Product Table 90. Avid Bioservices Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 91. Avid Bioservices Recent Development Table 92. Fujifilm Diosynth Biotechnologies Company Detail Table 93. Fujifilm Diosynth Biotechnologies Business Overview Table 94. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnologyProduct Table 95. Fujifilm Diosynth Biotechnologies Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 96. Fujifilm Diosynth Biotechnologies Recent Development Table 97. KBI Biopharma (JSR Corporation) Company Detail Table 98. KBI Biopharma (JSR Corporation) Business Overview Table 99. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnologyProduct Table 100. KBI Biopharma (JSR Corporation) Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 101. KBI Biopharma (JSR Corporation) Recent Development Table 102. Cytovance Biologics Company Detail Table 103. Cytovance Biologics Business Overview Table 104. Cytovance Biologics CMO and CDMO biotechnologyProduct Table 105. Cytovance Biologics Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 106. Cytovance Biologics Recent Development Table 107. Xpress Biologic Company Detail Table 108. Xpress Biologic Business Overview Table 109. Xpress Biologic CMO and CDMO biotechnologyProduct Table 110. Xpress Biologic Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 111. Xpress Biologic Recent Development Table 112. Rentschler Biopharma Company Detail Table 113. Rentschler Biopharma Business Overview Table 114. Rentschler Biopharma CMO and CDMO biotechnologyProduct Table 115. Rentschler Biopharma Revenue in CMO and CDMO biotechnology Business (2017-2022) & (US$ Million) Table 116. Rentschler Biopharma Recent Development Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global CMO and CDMO biotechnology Market Share by Type: 2021 VS 2028 Figure 2. Service Features Figure 3. Product Features Figure 4. Platform/ Expression System Features Figure 5. Global CMO and CDMO biotechnology Market Share by Application in 2021 & 2028 Figure 6. Large Enterprise Case Studies Figure 7. SME Case Studies Figure 8. CMO and CDMO biotechnology Report Years Considered Figure 9. Global CMO and CDMO biotechnology Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global CMO and CDMO biotechnology Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global CMO and CDMO biotechnology Market Share by Region: 2021 VS 2028 Figure 12. Global CMO and CDMO biotechnology Market Share by Players in 2021 Figure 13. Global Top CMO and CDMO biotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO and CDMO biotechnology as of 2021) Figure 14. The Top 10 and 5 Players Market Share by CMO and CDMO biotechnology Revenue in 2021 Figure 15. North America CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America CMO and CDMO biotechnology Market Share by Country (2017-2028) Figure 17. United States CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe CMO and CDMO biotechnology Market Share by Country (2017-2028) Figure 21. Germany CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific CMO and CDMO biotechnology Market Share by Region (2017-2028) Figure 29. China CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America CMO and CDMO biotechnology Market Share by Country (2017-2028) Figure 37. Mexico CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa CMO and CDMO biotechnology Market Share by Country (2017-2028) Figure 41. Turkey CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia CMO and CDMO biotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Patheon Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 44. Catalent Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 45. Samsung Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 46. Lonza. Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 47. Boehringer Ingelheim Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 48. Samsung BioLogics Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 49. AGC Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 50. WuXi Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 51. AbbVie Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 52. Avid Bioservices Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 53. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 54. KBI Biopharma (JSR Corporation) Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 55. Cytovance Biologics Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 56. Xpress Biologic Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 57. Rentschler Biopharma Revenue Growth Rate in CMO and CDMO biotechnology Business (2017-2022) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us